Alzheimer's Disease
Life Course Perspectives on Risk Reduction
- 1st Edition - February 11, 2016
- Latest edition
- Authors: Amy Borenstein, James Mortimer
- Language: English
Alzheimer's Disease: Lifecourse Perspectives on Risk Reduction summarizes the growing body of knowledge on the distribution and causes of Alzheimer’s disease (AD) in human pop… Read more
Data Mining & ML
Unlock the cutting edge
Up to 20% on trusted resources. Build expertise with data mining, ML methods.
Description
Description
Alzheimer's Disease: Lifecourse Perspectives on Risk Reduction summarizes the growing body of knowledge on the distribution and causes of Alzheimer’s disease (AD) in human populations, providing the reader with knowledge on how we define the disease and what its risk and protective factors are in the context of a life-course approach.
At the conclusion of the book, the reader will understand why Alzheimer’s disease likely begins at conception, then progresses through early-life and adult risk factors that ultimately impact the balance between pathologic insults in the brain and the ability of the brain to modify disease symptoms. In contrast to edited volumes that may have little cohesion, this book focuses on an integrated life-course approach to the epidemiology of dementia, in particular, Alzheimer’s disease.
Key features
Key features
- Reviews the current science surrounding Alzheimer’s disease
- Provides a primer of foundational knowledge on the disease's epidemiology and biostatistics
- Utilizes a life-course approach, providing a novel and integrated view of the evolution of this illness from genes to brain reserve
- Uses the ‘threshold model’—a theory first described by Dr. Mortimer and widely accepted today—which incorporates the idea of risk factors for the pathology and expression of the disease
- Proposes that improving brain health through modifiable behaviors can delay disease onset until a later age
- Examines the future of prevention of Alzheimer’s disease, a subject of great current interest
Readership
Readership
Researchers, clinicians, and students in psychology, gerontology, public health, and epidemiology who work with an Alzheimer’s/dementia population.
Table of contents
Table of contents
Prologue: A Primer on Epidemiologic Concepts and MethodsSection 1. Defining a CaseChapter 1. The "First" CaseChapter 2. Clinical Appearance, Progression, and ClassificationChapter 3. Epidemiologic Definition of a CaseChapter 4. Neuropathology of Alzheimer's DiseaseChapter 5. The Threshold Model of DementiaSection 2. Descriptive EpidemiologyChapter 6. The Prevalence of Alzheimer's DiseaseChapter 7. The Incidence of Alzheimer's DiseaseChapter 8. Survival and Mortality in Alzheimer's DiseaseSection 3. Analytic EpidemiologyChapter 9. Introduction to the Analytic Epidemiology of Azheimer's DiseaseChapter 10. Family History, Genetics, and Down Syndrome Chapter 11. Early-Life FactorsChapter 12. Traumatic Brain InjuryChapter 13. Gigarette Smoking and Alcohol ConsumptionChapter 14. Vascular DiseaseChapter 15. DietChapter 16. Physical ActivityChapter 17. Cognitive ActivityChapter 18. Social EngagementChapter 19. Non-Steroidal Anti-Inflammatory Drugs, Hormone Replacement Therapy, and Anticholinergic MedicationsSection 4. Epidemiologic and Biologic MarkersChapter 20. Prodromal Markers of Disease or Causal Risk Factors? Depression, Olfaction, and Subjective Memory ComplaintsChapter 21. Fluid, Imaging, and Cognitive Biomarkers
Section 5. Future StepsChapter 22. Risk Assessment and Prevention of Alzheimer's DiseaseChapter 23. Summary and Recommendations
Review quotes
Review quotes
"Drs. Borenstein and Mortimer have produced a remarkable text on the topic of the epidemiology of Alzheimer’s disease that is destined to become a classic in the field. These scholars have used methodological rigor to dissect a complicated area of study and have accomplished a tour de force for practitioners and scientists."—Ronald C. Petersen, PhD, MD, Mayo Clinic
"In this book, two of the world leaders of dementia epidemiology summarize their knowledge gained over more than four decades. Essential for researchers, clinicians and others interested in the distribution, causes and consequences of Alzheimer’s disease, this book will be a standard reference in dementia epidemiology for many years."—Ingmar Skoog, PhD, MD, University of Gothenburg
"An important book and a must for epidemiologists and physicians studying dementia in populations."—Jean François Dartigues, PhD, MD, University of Bordeaux
Product details
Product details
- Edition: 1
- Latest edition
- Published: February 11, 2016
- Language: English
About the authors
About the authors
AB
Amy Borenstein
JM